The Hatch-Waxman Act: Encouraging Innovation and Generic Drug Competition

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|10|18|1950-1959

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.10, Iss.18, 2010-12, pp. : 1950-1959

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Generic Drug Regulation in the US Under the Hatch-Waxman Act: A Balance Between Competition and Innovation or Confusion and Intrigue?

By Milne C-P.   Cairns C.  

Pharmaceutical Development and Regulation, Vol. 1, Iss. 1, 2003-01 ,pp. : 11-27

Adis International

Access to resources Recommend Favorite

Drug Discovery and the Impact of the Safe Harbor Provision of the Hatch-Waxman Act

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 18, 2010-12 ,pp. : 1960-1970

Bentham Science Publishers

Access to resources Recommend Favorite

Hatch-Waxman in the Federal Courts: From 1994–2004

By Ludwig S.   Kosinski Kristin Behrendt   Harris Jonathan  

Drug Development and Industrial Pharmacy, Vol. 31, Iss. 2, 2005-02 ,pp. : 215-222

Informa Healthcare

Access to resources Recommend Favorite

Judicial developments in the US Hatch-Waxman infringement safe harbor

By Swirnoff Alexander H   Becker Daniel M  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 4, 2010-04 ,pp. : 451-458

Informa Healthcare

Access to resources Recommend Favorite

Strategic considerations under the Biologics Price Competition and Innovation Act

By Marquardt John L  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 8, 2013-08 ,pp. : 915-918

Informa Healthcare

Access to resources Recommend Favorite